Shell Asset Management Co. Has $4.26 Million Stake in CVS Health Corporation $CVS

Shell Asset Management Co. grew its holdings in shares of CVS Health Corporation (NYSE:CVS) by 33.5% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 61,776 shares of the pharmacy operator’s stock after acquiring an additional 15,491 shares during the quarter. Shell Asset Management Co.’s holdings in CVS Health were worth $4,261,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Bell Investment Advisors Inc raised its stake in CVS Health by 119.8% during the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock worth $31,000 after acquiring an additional 248 shares in the last quarter. Roxbury Financial LLC grew its holdings in shares of CVS Health by 78.3% during the second quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock worth $32,000 after purchasing an additional 202 shares during the last quarter. ORG Partners LLC grew its holdings in shares of CVS Health by 418.9% during the second quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock worth $32,000 after purchasing an additional 377 shares during the last quarter. Saudi Central Bank bought a new stake in shares of CVS Health during the first quarter worth about $34,000. Finally, Livelsberger Financial Advisory bought a new stake in shares of CVS Health during the second quarter worth about $35,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Price Performance

Shares of CVS opened at $77.17 on Wednesday. CVS Health Corporation has a 52-week low of $43.56 and a 52-week high of $79.20. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.62 and a current ratio of 0.80. The business’s 50 day moving average price is $71.39 and its two-hundred day moving average price is $67.46. The firm has a market cap of $97.88 billion, a PE ratio of 21.56, a price-to-earnings-growth ratio of 0.85 and a beta of 0.60.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.46 by $0.35. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.The firm had revenue of $98.92 billion for the quarter, compared to analyst estimates of $94.87 billion. During the same period in the previous year, the firm earned $1.83 earnings per share. The company’s revenue was up 8.4% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. On average, equities analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd will be given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.4%. The ex-dividend date of this dividend is Thursday, October 23rd. CVS Health’s dividend payout ratio is presently 74.30%.

Insider Buying and Selling at CVS Health

In other news, Director Anne A. Finucane sold 7,500 shares of the company’s stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total transaction of $532,650.00. Following the transaction, the director directly owned 22,156 shares of the company’s stock, valued at $1,573,519.12. This represents a 25.29% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.22% of the stock is owned by insiders.

Wall Street Analyst Weigh In

CVS has been the topic of several research reports. Wells Fargo & Company boosted their price target on CVS Health from $84.00 to $103.00 and gave the stock an “overweight” rating in a report on Tuesday. Sanford C. Bernstein boosted their price target on CVS Health from $72.00 to $77.00 and gave the stock a “market perform” rating in a report on Friday, September 5th. Zacks Research cut CVS Health from a “strong-buy” rating to a “hold” rating in a report on Monday, September 8th. Robert W. Baird upgraded CVS Health from a “neutral” rating to an “outperform” rating and upped their target price for the company from $71.00 to $82.00 in a report on Thursday, August 14th. Finally, Bernstein Bank reduced their target price on CVS Health from $78.00 to $72.00 and set a “market perform” rating on the stock in a report on Wednesday, July 16th. Two analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, CVS Health presently has a consensus rating of “Moderate Buy” and an average target price of $79.20.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.